✦ LIBER ✦

Coagulation Disorders and Bleeding in Liver Disease: Future Directions

✍ Scribed by Caldwell, Stephen H.; Sanyal, Arun J.

Book ID: 123097058
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 58 KB
Volume: 13
Category: Article
ISSN: 1089-3261
DOI: 10.1016/j.cld.2008.09.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New concepts of coagulation and bleeding

New concepts of coagulation and bleeding in liver disease

✍ Patrick G. Northup; Stephen H. Caldwell 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 123 KB

Review article: coagulation disorders in

Review article: coagulation disorders in chronic liver disease

✍ M. PECK-RADOSAVLJEVIC 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Bacterial infections in end-stage liver

Bacterial infections in end-stage liver disease: current challenges and future directions

✍ Bajaj, J. S.; O'Leary, J. G.; Wong, F.; Reddy, K. R.; Kamath, P. S. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 135 KB

Coagulation factor activity and clinical

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

✍ F. PEYVANDI; R. PALLA; M. MENEGATTI; S. M. SIBONI; S. HALIMEH; B. FAESER; H. PER 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Future directions for immune modulation

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease

✍ Kathleen A. Maguire-Zeiss; Howard J. Federoff 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB

Coagulation disorders and hemostasis in

Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management

✍ Stephen H. Caldwell; Maureane Hoffman; Ton Lisman; B. Gail Macik; Patrick G. Nor 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Normal coagulation has classically been conceptualized as a Y-shaped pathway, with distinct "intrinsic" and "extrinsic" components initiated by factor XII or factor VIIa/ tissue factor, respectively, and converging in a "common" pathway at the level of the FXa/FVa (prothrombinase) complex. Until rec